Results 181 to 190 of about 15,166 (224)
Some of the next articles are maybe not open access.
Seminars in Cutaneous Medicine and Surgery, 2005
Sclerosant microfoam is composed of microbubbles of room or air carbon dioxide (CO(2)). When air is mixed into the surfactant liquid sclerosant, microbubbles of reduced diameter can be obtained of sufficient stability to be injected into the vessels. The area of liquid on the surface is enormously increased in inverse proportion to the diameter of the ...
Pedro, Redondo, Juan, Cabrera
openaire +2 more sources
Sclerosant microfoam is composed of microbubbles of room or air carbon dioxide (CO(2)). When air is mixed into the surfactant liquid sclerosant, microbubbles of reduced diameter can be obtained of sufficient stability to be injected into the vessels. The area of liquid on the surface is enormously increased in inverse proportion to the diameter of the ...
Pedro, Redondo, Juan, Cabrera
openaire +2 more sources
Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2017
Telangiectasias and spider veins are considered a common cosmetic concern for both women and men. Sclerotherapy is a frequently used, low-risk, and highly successful method to treat these venous problems. This article reviews the pathophysiology and diagnosis of telangiectasias and reticular veins as well as the currently available agents and ...
Jennifer J, Watson, M Ashraf, Mansour
openaire +2 more sources
Telangiectasias and spider veins are considered a common cosmetic concern for both women and men. Sclerotherapy is a frequently used, low-risk, and highly successful method to treat these venous problems. This article reviews the pathophysiology and diagnosis of telangiectasias and reticular veins as well as the currently available agents and ...
Jennifer J, Watson, M Ashraf, Mansour
openaire +2 more sources
Dermatologic Clinics, 1995
Although venous systems are inherently variable, the treatment of varicose and telangiectatic leg veins can be approached in a logical, systematic fashion (Table 4). Instead of randomly injecting as many veins as possible in a given period of time, venous regions or entire abnormal superficial venous networks related to incompetent perforators should ...
R A, Weiss, M P, Goldman
openaire +2 more sources
Although venous systems are inherently variable, the treatment of varicose and telangiectatic leg veins can be approached in a logical, systematic fashion (Table 4). Instead of randomly injecting as many veins as possible in a given period of time, venous regions or entire abnormal superficial venous networks related to incompetent perforators should ...
R A, Weiss, M P, Goldman
openaire +2 more sources
Sclerotherapy and foam sclerotherapy for varicose veins
Phlebology: The Journal of Venous Disease, 2009Objectives To review published evidence concerning treatment of varicose veins using ultrasound-guided foam sclerotherapy (UGFS) to assess the safety and efficacy of this treatment. Methods Medical literature databases including MedLine, Embase and DH-DATA were searched for recent literature concerning UGFS.
openaire +2 more sources
Phlebology: The Journal of Venous Disease, 2015
Foam sclerotherapy is a minimally invasive treatment for lower limb varicose veins. Current evidence indicates that its efficacy may not be as high as surgery or endovenous ablation. The minimally invasive nature of the treatment however means that it has a wide application, and it can be particularly useful in patients who are not suitable for other ...
Glen, Alder, Tim, Lees
openaire +2 more sources
Foam sclerotherapy is a minimally invasive treatment for lower limb varicose veins. Current evidence indicates that its efficacy may not be as high as surgery or endovenous ablation. The minimally invasive nature of the treatment however means that it has a wide application, and it can be particularly useful in patients who are not suitable for other ...
Glen, Alder, Tim, Lees
openaire +2 more sources
The Journal of Dermatologic Surgery and Oncology, 1988
Abstract. A low‐cost, easy‐to‐use, and readily available addition to the syringe‐needle unit commonly employed in sclerotherapy is described. A small‐bore plastic tube inserted between needle and syringe will increase mobility and accessibility when performing sclerotherapy.
P J, Weber, L M, Dzubow
openaire +2 more sources
Abstract. A low‐cost, easy‐to‐use, and readily available addition to the syringe‐needle unit commonly employed in sclerotherapy is described. A small‐bore plastic tube inserted between needle and syringe will increase mobility and accessibility when performing sclerotherapy.
P J, Weber, L M, Dzubow
openaire +2 more sources
Dermatologic Surgery, 2014
The American Society for Dermatologic Surgery (ASDS) periodically develops consensus documents for its members concerning various aspects of dermatologic surgery. Unwanted and painful leg veins are a very widespread problem. Many advances in sclerotherapy of varicose and telangiectatic leg veins have occurred since the previous consensus documents.In ...
Margaret A, Weiss +4 more
openaire +2 more sources
The American Society for Dermatologic Surgery (ASDS) periodically develops consensus documents for its members concerning various aspects of dermatologic surgery. Unwanted and painful leg veins are a very widespread problem. Many advances in sclerotherapy of varicose and telangiectatic leg veins have occurred since the previous consensus documents.In ...
Margaret A, Weiss +4 more
openaire +2 more sources
Telangiectasia and Sclerotherapy
The Journal of Dermatologic Surgery and Oncology, 1989Abstract. The anatomy, physiology, and etiology of telangiectasia and related varicosities of the lower limbs are presented. Treatment by sclerotherapy is discussed, with various modalities investigated and compared.
openaire +2 more sources
Plastic Surgical Nursing, 2000
Sclerotherapy is the direct injection of a sclerosing agent, such as hypertonic saline, into a visible vein or telangectasia. The solution is designed to irritate or dehydrate, change surface tension, or destroy the endothelial cells to produce initially a small thrombosis and then permanent fibrosis of the vein.
openaire +2 more sources
Sclerotherapy is the direct injection of a sclerosing agent, such as hypertonic saline, into a visible vein or telangectasia. The solution is designed to irritate or dehydrate, change surface tension, or destroy the endothelial cells to produce initially a small thrombosis and then permanent fibrosis of the vein.
openaire +2 more sources
Dermatologic Clinics, 2004
Sclerotherapy involves the injection of a fluid into blood vessels to eradicate them. A thorough understanding of the basics of sclerotherapy are important when beginning sclerotherapy procedures in practice. This article reviews the essential information of sclerosants, treatment of small vessel disease, and patient management.
openaire +2 more sources
Sclerotherapy involves the injection of a fluid into blood vessels to eradicate them. A thorough understanding of the basics of sclerotherapy are important when beginning sclerotherapy procedures in practice. This article reviews the essential information of sclerosants, treatment of small vessel disease, and patient management.
openaire +2 more sources